🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Diabetic patients have an excess risk of mortality due to cardiovascular di...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00965315
Treatments Being Tested
Previous studies indicate that the variant status of detoxification protein...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00934258
Treatments Being Tested
The primary objective is to determine the efficacy of AMR101 (ethyl icosape...
Status
Completed
Location
Amarin Investigational Site
Start Date
2009-12
Trial ID
NCT01047501
Treatments Being Tested
Efficacy and safety of combination therapy of rosuvastatin and fenofibrate ...
Status
Completed
Location
Ildong Pharm.
Start Date
2014-11
Trial ID
NCT02262143
Treatments Being Tested
The purpose of the study is to determine the efficacy of lapaquistat acetat...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00251680
Treatments Being Tested
The purpose of this study is to determine effects of combination therapy wi...
Status
Unknown
Location
Konyang University Hospital
Start Date
2014-01
Trial ID
NCT02232360
Treatments Being Tested
This is a multiple-dose, double-blind, randomized, single-center, parallel-...
Status
Completed
Location
Site Ref # / Investigator 5290
Start Date
2007-06
Trial ID
NCT00487136
Primary Objective: To compare the efficacy of alirocumab (Praluent®) with ...
Status
Completed
Location
Investigational Site Number 392026
Start Date
2016-11-15
Trial ID
NCT02984982
AMR101 (icosapent ethyl \[ethyl-EPA\]) is a highly purified ethyl ester of ...
Status
Completed
Location
Amarin Investigational Site
Start Date
2011-11
Trial ID
NCT01492361
Treatments Being Tested
The primary purpose of this study is to test the safety and the effects of ...
Status
Completed
Location
Global Medical Information
Start Date
2006-09
Trial ID
NCT00300430
Treatments Being Tested